In particular, serum from pediatric lupus patients induces neutrophil apoptosis, which is abrogated by granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment, suggesting a potential therapeutic benefit of GM-CSF in SLE patients (55). This evidence concerns the gene CSF2 and systemic lupus erythematosus.